Jeffrey Cohen, MD

Articles

Key Takeaways on the Management of Atopic Dermatitis

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 23rd 2022

Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.

Ongoing Challenges in the Management of Atopic Dermatitis

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 23rd 2022

Experts share insight on the challenges inherent in treating patients with atopic dermatitis despite recent advances in therapy.

Atopic Dermatitis: Practical Advice on Selecting and Using JAK Inhibitors

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 16th 2022

Concluding their focused discussion on JAK inhibitors in atopic dermatitis, panelists share advice on the optimal selection based on route of administration and use of these agents.

Recent Approval of Oral JAK Inhibitors for Atopic Dermatitis

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 16th 2022

A brief review of 2 oral JAK inhibitors recently approved for patients with atopic dermatitis.

Topical Ruxolitinib Use in Atopic Dermatitis

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 9th 2022

A panel of experts review the use of topical ruxolitinib in atopic dermatitis, shedding light on safety and efficacy considerations.

JAK Inhibitors in Atopic Dermatitis: Historical Use and Mechanisms of Action

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 9th 2022

Focusing on JAK inhibitors, panelists consider the historical use of these agents in atopic dermatitis and their corresponding mechanisms of action.

Treatment for Mild to Moderate vs Moderate to Severe Atopic Dermatitis

Christopher G. Bunick, MD, PhD;Jeffrey Cohen, MD;Linda Stein Gold, MD;Peter Lio, MD

March 2nd 2022

Experts define stages of atopic dermatitis and share insight on the conventional treatment landscape for mild to moderate and moderate to severe atopic dermatitis.

Atopic Dermatitis Overview: Pathophysiology, Diagnosis, and Burden

Christopher G. Bunick, MD, PhD;Linda Stein Gold, MD;Peter Lio, MD;Jeffrey Cohen, MD

March 2nd 2022

Expert perspectives on the nature of atopic dermatitis, ranging from diagnosis and pathophysiology to the clinical and social burden it places on patients.